









市场行情
/
股票
/
nasdaq-dmaau
/

Drugs Made In America Acquisition Corp

DMAAU

10.490USD

0.000

收盘 12/19, 16:00（美东）报价延迟15分钟

0.00总市值

--市盈率 TTM



Drugs Made In America Acquisition Corp

10.490

0.000

概览公司财务分析

概览

公司

财务

分析

关于 Drugs Made In America Acquisition Corp 公司

Drugs Made In America Acquisition Corp. is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combination with one or more businesses. The Company intends to focus its search for businesses in the pharmaceutical industry. The Company has neither engaged in any operations nor generated any revenues.

Drugs Made In America Acquisition Corp简介



公司代码DMAAU

公司名称Drugs Made In America Acquisition Corp

上市日期Jan 28, 2025

CEOStockwell (Lynn)

员工数量- -

证券类型Unit

年结日- -

公司地址1 East Broward Boulevard

城市FT LAUDERDALE

上市交易所NASDAQ OMX - NASDAQ BASIC

国家United States of America

邮编33301

电话19548703099

网址

公司代码DMAAU

上市日期Jan 28, 2025

CEOStockwell (Lynn)

Drugs Made In America Acquisition Corp公司高管



名称

名称/职务

职务

持股

持股变动

Dr. G. Sridhar Prasad

Independent Director Nominee

Mr. Myron W. Shulgan

Independent Director Nominee

Ms. Lynn Stockwell

Executive Chairman of the Board, Chief Executive Officer

Dr. Catherine Do

Independent Director Nominee

Mr. Saleem Elmasri, CPA

Chief Financial Officer, Principal Financial and Accounting Officer

名称

名称/职务

职务

持股

持股变动

Dr. G. Sridhar Prasad

Independent Director Nominee

Mr. Myron W. Shulgan

Independent Director Nominee

Ms. Lynn Stockwell

Executive Chairman of the Board, Chief Executive Officer

Dr. Catherine Do

Independent Director Nominee

Mr. Saleem Elmasri, CPA

Chief Financial Officer, Principal Financial and Accounting Officer

收入明细

由于公司未披露，未能获取相关数据

由于公司未披露，未能获取相关数据

业务

地区

由于公司未披露，未能获取相关数据

股东统计

更新时间: 11月17日周一

持股股东

股东类型

持股股东

占比

Drugs Made In America Acquisition LLC

17.88%

Kryger Capital Limited

1.28%

Wolverine Asset Management, LLC

0.55%

RiverNorth Capital Management LLC

0.44%

Clear Street Group Inc

0.20%

其他

79.65%

持股股东

占比

Drugs Made In America Acquisition LLC

17.88%

Kryger Capital Limited

1.28%

Wolverine Asset Management, LLC

0.55%

RiverNorth Capital Management LLC

0.44%

Clear Street Group Inc

0.20%

其他

79.65%

股东类型

持股股东

占比

Corporation

17.88%

Investment Advisor

1.56%

Investment Advisor/Hedge Fund

0.65%

Hedge Fund

0.61%

Research Firm

0.20%

其他

79.11%

机构持股



更新时间: 12月8日周一

报告期

机构数

持股数

持股占比

持股变动

2025Q4

706.12K

14.40%

2025Q3

706.12K

14.40%

-280.00K

2025Q2

986.13K

14.72%

-2.41M

2025Q1

3.40M

0.80%

+3.21M

股东持股明细



名称

持股数

占比

持股变动

变动比例

公告日期

Drugs Made In America Acquisition LLC

4.19M

17.88%

+4.19M

Feb 18, 2025

Wolverine Asset Management, LLC

130.00K

0.55%

Jun 30, 2025

RiverNorth Capital Management LLC

420.50K

1.79%

Jun 30, 2025

Clear Street LLC

45.92K

0.2%

+40.07K

+685.09%

Jun 30, 2025

Robinson Capital Management, LLC

30.00K

0.13%

+20.00K

+200.00%

Jun 30, 2025

Tuttle Capital Management, LLC

20.00K

0.09%

-20.00K

-50.00%

Jun 30, 2025

UBS Financial Services, Inc.

18.39K

0.08%

+107.00

+0.59%

Jun 30, 2025

Citadel Advisors LLC

14.03K

0.06%

-1.73K

-10.96%

Jun 30, 2025

持股ETF



更新时间: 12月6日周六

机构名称

占比

CrossingBridge Pre-Merger SPAC ETF

SPAC and New Issue ETF

RiverNorth Enhanced Pre-Merger SPAC ETF

CrossingBridge Pre-Merger SPAC ETF

占比0%

SPAC and New Issue ETF

占比0%

RiverNorth Enhanced Pre-Merger SPAC ETF

占比0%

分红派息



近5年累计派现 0.00 美元

公告日期

分红计划

股权登记日

现金发放日

除权除息日

暂无数据

拆合股



公告日期

类型

比率

暂无数据

公告日期

类型

比率

暂无数据

常见问题

Drugs Made In America Acquisition Corp的前五大股东是谁？



Drugs Made In America Acquisition Corp 的前五大股东如下：
Drugs Made In America Acquisition LLC持有股份：4.19M，占总股份比例：17.88%。
Wolverine Asset Management, LLC持有股份：130.00K，占总股份比例：0.55%。
RiverNorth Capital Management LLC持有股份：420.50K，占总股份比例：1.79%。
Clear Street LLC持有股份：45.92K，占总股份比例：0.20%。
Robinson Capital Management, LLC持有股份：30.00K，占总股份比例：0.13%。